Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/w34m-zf84

technical paper

ENDO 2020

June 10, 2020

Virtual, United States

Innovations in Treatments: Device- and Drug-Based Approaches for Management of T1D

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2020

Phase 3 FliGHt Trial: Experience of Switching from Daily Growth Hormone Therapy to Once-Weekly TransCon HGH in Children with Growth Hormone Deficiency
technical paper

Phase 3 FliGHt Trial: Experience of Switching from Daily Growth Hormone Therapy to Once-Weekly TransCon HGH in Children with Growth Hormone Deficiency

ENDO 2020

+11Larry A. FoxAristides Maniatis
Aristides Maniatis and 13 other authors

10 June 2020

Similar lecture

Epinephrine Is Essential for Normal Renal Glucose Reabsorption via the Glucose Transporter GLUT2
technical paper

Epinephrine Is Essential for Normal Renal Glucose Reabsorption via the Glucose Transporter GLUT2

ENDO 2020

+2Kavaljit H. ChhabraArwa Mahmoud Elsheikh
Arwa Mahmoud Elsheikh and 4 other authors

10 June 2020

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved